Published in Ann Surg on September 01, 2007
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med (2010) 1.53
Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response. Ann Surg (2012) 1.21
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg (2009) 1.20
Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg (2012) 1.19
Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg (2009) 1.09
The surgically induced stress response. JPEN J Parenter Enteral Nutr (2013) 0.96
Burns: an update on current pharmacotherapy. Expert Opin Pharmacother (2012) 0.95
Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? Curr Opin Clin Nutr Metab Care (2011) 0.92
Long-term oxandrolone treatment increases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury. Surgery (2011) 0.89
Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study. Shock (2015) 0.86
The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes. PLoS One (2012) 0.84
What, how, and how much should patients with burns be fed? Surg Clin North Am (2011) 0.83
Hormone treatment and muscle anabolism during aging: androgens. Clin Nutr (2010) 0.83
Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models. Int J Mol Sci (2016) 0.82
Bacterial respiratory tract infections are promoted by systemic hyperglycemia after severe burn injury in pediatric patients. Burns (2013) 0.81
Postburn Hypermetabolism: Past, Present, and Future. J Burn Care Res (2016) 0.78
The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev (2016) 0.78
Acellular Hydrogels for Regenerative Burn Wound Healing: Translation from a Porcine Model. J Invest Dermatol (2015) 0.77
Impact of oxandrolone treatment on acute outcomes after severe burn injury. J Burn Care Res (2008) 0.77
Hypermetabolism and hypercatabolism of skeletal muscle accompany mitochondrial stress following severe burn trauma. Am J Physiol Endocrinol Metab (2016) 0.75
Nutrition and metabolism in burn patients. Burns Trauma (2017) 0.75
FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL. Shock (2016) 0.75
The occurrence of single and multiple organ dysfunction in pediatric electrical versus other thermal burns. J Trauma Acute Care Surg (2017) 0.75
Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies. Pediatr Crit Care Med (2017) 0.75
Early Enteral Nutrition for Burn Injury. Adv Wound Care (New Rochelle) (2014) 0.75
Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2. Pediatr Crit Care Med (2017) 0.75
The P50 Research Center in Perioperative Sciences: How the investment by the National Institute of General Medical Sciences in Team Science has reduced post-burn mortality. J Trauma Acute Care Surg (2017) 0.75
The biochemical alterations underlying post-burn hypermetabolism. Biochim Biophys Acta (2017) 0.75
Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg (1974) 4.48
Reversal of catabolism by beta-blockade after severe burns. N Engl J Med (2001) 4.02
Support of the metabolic response to burn injury. Lancet (2004) 3.06
Determinants of skeletal muscle catabolism after severe burn. Ann Surg (2000) 2.56
Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33
Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care (1999) 2.16
Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol (1985) (2001) 1.93
Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med (2007) 1.77
Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med (2001) 1.76
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest (1996) 1.67
Anabolic effects of oxandrolone after severe burn. Ann Surg (2001) 1.65
Muscle protein turnover and the wasting due to injury and disease. Br Med Bull (1985) 1.64
The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60
Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59
Growth delay in postburn pediatric patients. Arch Surg (1990) 1.56
Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab (2002) 1.55
Metabolic changes in burned patients. Surg Clin North Am (1978) 1.54
Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (1995) 1.51
Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. Pediatrics (2006) 1.42
Long-term reduction in bone mass after severe burn injury in children. J Pediatr (1995) 1.37
Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg (2005) 1.34
Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns. J Appl Physiol (1985) (2003) 1.23
Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab (1999) 1.20
Effect of exercise training on pulmonary function in children with thermal injury. J Burn Care Rehabil (2002) 1.17
Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock (1998) 1.15
Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med (2000) 1.13
Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab (2002) 1.12
Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res (2006) 1.09
Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma (2007) 1.09
Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines. Arch Surg (1994) 1.08
The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs (2004) 1.08
Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr (1996) 1.06
The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care (2000) 1.06
Gene expression patterns in skeletal muscle of thermally injured children treated with oxandrolone. Ann Surg (2003) 1.04
Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. Ann Surg (2003) 1.03
Androgens and the control of skeletal muscle protein synthesis. Ann Med (2000) 1.00
Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab (2004) 0.97
Increased liver weights in severely burned children: comparison of ultrasound and autopsy measurements. Burns (2004) 0.95
Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr Nephrol (2000) 0.93
AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J Acquir Immune Defic Syndr (2003) 0.93
The management of acute bone loss in severe catabolism due to burn injury. Horm Res (1997) 0.87
The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. J Trauma (2004) 0.87
Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: an in-vivo microdialysis study. Physiol Res (2005) 0.87
Muscle protein metabolism during sepsis. Biochem Soc Trans (1995) 0.86
Oxandrolone blocks glucocorticoid signaling in an androgen receptor-dependent manner. Steroids (2004) 0.85
Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen (2000) 0.85
Treatment with oxandrolone and the durability of effects in older men. J Appl Physiol (1985) (2003) 0.85
Six-week improvements in muscle mass and strength during androgen therapy in older men. J Gerontol A Biol Sci Med Sci (2005) 0.85
Oxandrolone treatment of childhood hereditary angioedema. Ann Allergy Asthma Immunol (2004) 0.83
Closure of the "non-healing wound" corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy Wound Manage (1998) 0.82
Testosterone and muscle protein metabolism. Mayo Clin Proc (2000) 0.82
The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf) (1993) 0.81
Nutritional and pharmacological support of the metabolic response to injury. Minerva Anestesiol (2003) 0.79
Drug increases lean tissue mass in patients with cancer. Lancet Oncol (2003) 0.77
Hepatic effects of 17 alpha-alkylated anaboli-androgenic steroids. HIV Hotline (1998) 0.76
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A (2009) 2.66
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33
Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity (2004) 2.29
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol (2004) 2.25
Preclinical evaluation of epinephrine nebulization to reduce airway hyperemia and improve oxygenation after smoke inhalation injury. Crit Care Med (2011) 2.10
Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg (2014) 2.03
Impaired zinc and copper status in children with burn injuries: need to reassess nutritional requirements. Burns (2005) 1.98
Burn size determines the inflammatory and hypermetabolic response. Crit Care (2007) 1.97
A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med (2002) 1.95
Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg (2010) 1.78
Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med (2007) 1.77
Synthesis of vitamin D in skin after burns. Lancet (2004) 1.75
Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med (2008) 1.73
Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71
Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med (2009) 1.68
Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67
Morbidity and survival probability in burn patients in modern burn care. Crit Care Med (2015) 1.67
Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med (2002) 1.66
Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med (2007) 1.62
Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol (2005) 1.62
Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg (2004) 1.61
The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60
Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit Care Med (2004) 1.59
Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59
The leading causes of death after burn injury in a single pediatric burn center. Crit Care (2009) 1.59
Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol (2003) 1.58
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Prediction of mortality from catastrophic burns in children. Lancet (2003) 1.58
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med (2002) 1.58
Hypoglycemia is associated with increased postburn morbidity and mortality in pediatric patients. Crit Care Med (2014) 1.58
Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med (2009) 1.57
Skin nitric oxide and its metabolites are increased in nonburned skin after thermal injuries. Shock (2004) 1.56
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med (2010) 1.53
Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med (2006) 1.52
The effect of growth hormone on gut mucosal homeostasis and cellular mediators after severe trauma. J Surg Res (2005) 1.52
Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int (2004) 1.52
Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49
A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48
Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med (2010) 1.46
Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection. J Leukoc Biol (2009) 1.46
Wound coverage technologies in burn care: novel techniques. J Burn Care Res (2013) 1.45
IGF-I gene transfer effects on inflammatory elements present after thermal trauma. Am J Physiol Regul Integr Comp Physiol (2003) 1.43
Beneficial effects of concomitant neuronal and inducible nitric oxide synthase inhibition in ovine burn and inhalation injury. Shock (2011) 1.42
The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery (2005) 1.42
The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. Pediatrics (2006) 1.42
The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg (2007) 1.41
Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN J Parenter Enteral Nutr (2011) 1.41
Calcium and ER stress mediate hepatic apoptosis after burn injury. J Cell Mol Med (2009) 1.40
Changes in liver function and size after a severe thermal injury. Shock (2007) 1.39
Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit Care Med (2002) 1.39
Reported stress of parents of burned children differs on the Spanish and English versions of the parenting stress inventory. J Burn Care Rehabil (2005) 1.38
Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg (2007) 1.36
Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet (2012) 1.36
Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma (2003) 1.34
Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock (2008) 1.34
A review of gene and stem cell therapy in cutaneous wound healing. Burns (2008) 1.34
Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg (2005) 1.34